Month: July 2020

BARRIE, Ontario, July 29, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it will supply premium, pharmaceutical-quality cannabis products to Hybrid Pharm Inc. (“Hybrid Pharm”), a modern wellness pharmacy and medical cannabis sales licence holder serving patients in the Ottawa region.Partnering with MediPharm Labs as a trusted supplier, Hybrid Pharm is unique among pharmacies in Canada in that it provides medical cannabis patients with a full in-store experience including consultation services. Hybrid Pharm’s qualified pharmacists work closely with healthcare practitioners to provide same day registration and delivery,...

PETAH TIKVA, Israel, July 29, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announces the award of a cellular backhaul project for Kcell, Kazakhstan’s largest Mobile Network Operator (MNO). Gilat will provide connectivity starting with hundreds of rural villages, in partnership with Kazakhstan’s recognized service provider, TelService LTD, to satisfy the “Digital Kazakhstan” government program.“We are pleased to be utilizing Gilat’s globally recognized cellular backhaul solution over satellite, to provide rural coverage to the villages which require voice and data services,” said Chief Technical Officer, Mr. Askar Yesserkegenov at Kcell. “We are honored to be part of the ‘Digital...

RESEARCH TRIANGLE PARK, N.C., July 29, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it will host a webcast and conference call to provide a corporate and financial update for the second quarter of 2020 on Wednesday, August 5, 2020 at 5:00 p.m. ET.The live call may be accessed by dialing 866-763-6020 (domestic) or 210-874-7713 (international) and entering the conference code: 4648036. The live and archived webcast will be available on the Events & Presentations page of the G1 website.About G1 TherapeuticsG1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer. The company is advancing three clinical-stage programs. Trilaciclib...

BARRIE, Ontario, July 29, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that MediPharm Labs’ management will participate in the “Cannabis Chronicles” Fireside Chat with Alliance Global Senior Analyst Aaron Grey on Friday, July 31st. What: Audio Video Webcast PresentationWhen: Friday, July 31, 2020 at 10:30am Eastern TimeWhere: Webcast link https://us02web.zoom.us/webinar/register/WN_2dREgIgnSIezAIifIZD6kg or through the events section of MediPharm Labs Investor Relations website at https://ir.medipharmlabs.com/ir-calendar.About MediPharm LabsFounded in 2015, MediPharm Labs specializes in the production of...

MIGDAL HA’EMEK, Israel, July 29, 2020 (GLOBE NEWSWIRE) — PV Nano Cell Ltd. (OTC: PVNNF), (the “Company”), an innovative provider of inkjet-based conductive digital printing solutions and producer of conductive digital inks, today announced it has opened a new site for its application team and printers. The new site will house the company’s application team to serve the increasing number of customers in need for printing solutions, process development and printing services.The new offices are located close to the company’s headquarters in Migdal Ha’Emek, Israel and host several DemonJet printers and a mass production printer. The offices are fully equipped with microscopes, sintering ovens and electrical measurement tools. The new location will also serve as a demo center for visiting customers to see the company’s...

Horizon Discovery Group plcHalf Year Trading UpdateBusiness remains robust with sustained recovery to 2019 levels as demand for Horizon’s products and services remains highGroup is confident of a return to growth in H2 2020Capital markets webinar 15:00 BST today – dial in details belowCambridge, UK, 29 July 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Group” or “the Company”), a cell engineering company focused on commercialising the application of gene editing and gene modulation to accelerate scientific innovation and biopharmaceutical drug development, today provides an unaudited pre-close trading update for the six months ended 30 June 2020. The Company plans to report its half year 2020 results on 17 August 2020.FinancialsHorizon expects to report half year 2020 revenues of approximately £22.4...

AMRYT PHARMA PLC(“Amryt” or the “Company”)AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPEMonday, August 3, 2020 at 1000 ET / 1500 BSTDUBLIN, Ireland, and Boston MA, July 29 2020, Amryt (Nasdaq: AMYT, AIM: AMYT, Euronext Growth: AYP), a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, today announces it will host a Key Opinion Leader (KOL) call on Epidermolysis Bullosa (EB) disease on Monday, August 3, 2020 at 1000 ET (1500 BST).The call will feature a presentation by KOLs Harper Price, MD (Phoenix Children’s Hospital) and Brett Kopelan (debra of America) who will discuss the current disease landscape and unmet medical need in treating patients with EB. Dr....

TORONTO, July 29, 2020 (GLOBE NEWSWIRE) — Global Atomic Corporation (“Global Atomic” or the “Company”; TSX:GLO; OTCQX: GLATF; Frankfurt: G12) announced today that significant progress has been made towards submitting it’s Mining Permit application for the Dasa Uranium Project in the Republic of Niger, West Africa. HIGHLIGHTS:In July,The Company filed its completed Environmental Impact Statement (“EIS”), with the Niger Government;The Dasa Project site hydrogeology drilling and water flow test work has been completed; andA tender for final geotechnical diamond drilling for the feasibility study has been issued.In August,Two public hearings in Niger regarding the EIS are being scheduled; one in the Dasa Project area and the other in the capital city of Niamey;the Company will begin a Pilot Plant test program to confirm Dasa process...

RAMSEY, N.J. and BOCA RATON, Fla., July 29, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the Company will host a live conference call and audio webcast on Wednesday, August 5, 2020 at 4:30 p.m. ET, to discuss its business highlights and financial results for the second quarter ended June 30, 2020.To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior to the start time and refer to conference ID 8992308. A live audio webcast of the call will be available under “Events & Webcasts” in the investor section of the Company’s website, https://ir.admabiologics.com/events-webcasts. An...